Filter
189
Filtered Results: 189
Text search:
M.
Doherty
Featured
Recommendations
13
New Publications
27
Language
Document type
No document type
73
Studies & Reports
57
Guidelines
42
Manuals
9
Training Material
5
Fact sheets
2
Strategic & Response Plan
1
Countries / Regions
Global
8
South Africa
8
Africa
7
Russia
4
Kenya
3
Lesotho
3
USA
3
Latin America and the Carribbean
3
Germany
3
Eastern Europe
3
Ukraine
2
Western and Central Europe
2
Uganda
2
Myanmar / Burma
2
Nepal
1
Rwanda
1
Chile
1
Nigeria
1
Burkina Faso
1
Malawi
1
Qatar
1
Mozambique
1
Armenia
1
Asia
1
Eastern Europe and Central Asia
1
United Kingdom
1
Portugal
1
Spain
1
Bangladesh
1
Brazil
1
Sri Lanka
1
Angola
1
Authors & Publishers
Publication Years
Category
Countries
31
Clinical Guidelines
27
Public Health
7
Women & Child Health
6
Key Resources
4
Capacity Building
3
Pharmacy & Technologies
3
Toolboxes
HIV
67
COVID-19
18
TB
17
Planetary Health
10
Caregiver
9
Disability
6
Mental Health
5
AMR
5
Global Health Education
4
NTDs
3
NCDs
3
Rapid Response
2
Refugee
2
Social Ethics
1
Background paper 8
The Independent Panel for Pandemic Preparedness and Response
May 2021
Rappart sur les populations clés.
Policy Brief, Updated in March 2017
High levels of storage iron may increase malaria susceptibility. This risk has not been investigated in semi-immune adolescents. We investigated whether baseline iron status of nonpregnant adolescent girls living in a high malaria transmission area in Burkina Faso affected malaria risk during the fo...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
Guidelines
HIV testing services
July 2015
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...
July 2019
Policy brief
HIV Treatment
Accessed: 03.03.2020
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
This UNAIDS 2024 report brings together new data and case studies which demonstrate that the decisions and policy choices taken by world leaders this year will decide the fate of millions of lives and whether the world’s deadliest pandemic is overcome.
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
The following protocol has been designed to investigate the First Few X cases (FFX) and their close contacts. It is envisioned that the FFX 2019-nCoV investigation will be conducted across several countries or sites with geographical and demographical diversity. Using a standardized protocol such a...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
